C. Christodoulou

Combination of Bisphosphonates and Antiangiogenic Factors Induces Osteonecrosis of the Jaw More Frequently than Bisphosphonates Alone

C. Christodoulou, A. Pervena, G. Klouvas et al. · Oncology · 2009 · 234 citations

Phase II study of temozolomide in heavily pretreated cancer patients with brain metastases

C. Christodoulou, Dimitrios Bafaloukos, P. Kosmidis et al. · Annals of Oncology · 2001 · 175 citations

Neuro-oncology, Brain Metastases, Medicine +8

Postoperative dose-dense sequential chemotherapy with epirubicin, followed by CMF with or without paclitaxel, in patients with high-risk operable breast cancer: a randomized phase III study conducted by the Hellenic Cooperative Oncology Group

George Fountzilas, Dimosthenis Skarlos, Urania Dafni et al. · Annals of Oncology · 2005 · 99 citations · Full text

Surgical Oncology, Breast Oncology, Medicine +5

EGF105084, a phase II study of lapatinib for brain metastases in patients (pts) with HER2+ breast cancer following trastuzumab (H) based systemic therapy and cranial radiotherapy (RT)

Nancy U. Lin, Véronique Dièras, D Paul et al. · Journal of Clinical Oncology · 2007 · 70 citations

Breast Oncology, Cranial Radiotherapy, Cancer Management +17

Paclitaxel and epirubicin versus paclitaxel and carboplatin as first-line chemotherapy in patients with advanced breast cancer: a phase III study conducted by the Hellenic Cooperative Oncology Group

George Fountzilas, Haralabos P. Kalofonos, Urania Dafni et al. · Annals of Oncology · 2004 · 68 citations · Full text

Advanced Breast Cancer, Breast Oncology, Medicine +7